Free Press Release

FaceBook Page Twitter Feed
You are here: Home > All News > British price breakthrough on Humanin S14G used in Alzheimers and diabetes research

British price breakthrough on Humanin S14G used in Alzheimers and diabetes research

Posted Nov 3, 2014 by AndrwDerAlex
1888 PressRelease - now offered worldwide as a dietary supplement spray.

FOR IMMEDIATE RELEASE (Press Release) Nov 3, 2014 -- Humanin was first discovered around the turn of the 21st century. It has since been widely touted by scientists worldwide as a revolutionary and potentially effective therapy for Alzheimer's, diabetes, and other neuropathic conditions.

However, as a dietary supplement the manufacturer is unable to legally make any claim for the new product as is normal for all dietary supplements. Links to the scientific background of the discovery are given on their new website at

Advantage Impex co UK Ltd is a specialist manufacturer of anti ageing supplement products. They operate as the Mackenzie Protocol and 21st Century Alternatives. They were the first British company to manufacture and distribute worldwide a competitively priced cycloastragenol based herbal supplement whilst still maintaining a high level of purity.

They now claim another British first with a dietary supplement spray called NeuroPep (UK) (tm)containing humanin S14G which is a revolutionary synthesised polypeptide found in the human body.

However, the manufacturer only offer their products to their own co-researcher club members and not the general public. Membership is free for non consumers expressing a genuine desire to research and test the supplement and a reseller club is also available for quantity purchasers interested in handling all their products at a discount. The discounted reseller items start at quantities of onlu 12 mixed items and are available worldwide.
-- EOF ---
Contact Email :
Issued By : 1888pressrelease
Country : United States
Categories : Health
Tags : Medical, health, Diabetes, Research
Last Updated : Nov 3, 2014

New Press News

blog comments powered by Disqus
Popular TagsMore